Table 1.
Formulation | Size (nm) | PDI | ζ potential (mV) | pH | α-bis content (mg mL−1) | Encapsulation (%) |
---|---|---|---|---|---|---|
α-bis-LNCs | 160±10 | 0.10±0.06 | −8.1±1.0 | 6.2±0.3 | 10.03±0.06 | 99.78±1.8 |
ULNCs | 168±5 | 0.11±0.08 | −7.9±1.2 | 6.05±0.5 | NA | NA |
Note: Data presented as mean ± standard deviation.
Abbreviations: α-bis, α-bisabolol; α-bis-LNCs, α-bis-loaded LNCs; LNCs, lipid-core nanocapsules; ULNCs, drug-unloaded nanocapsules; NA, not applicable; PDI, polydispersity index.